MARK S KAMINSKI, MD
Osteopathic Medicine in Ann Arbor, MI
License number
Michigan 4301049516
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301049516
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
1500 Floor Cancer & Geriatrics Ctr, Ann Arbor, MI 48109
Phone
(734) 936-9814
(734) 936-2047
(734) 936-2047
Personal information
See more information about MARK S KAMINSKI at radaris.comName
Address
Phone
504 Third St APT 8, Jackson, MI 49203
4848 Starak Ln, Ann Arbor, MI 48105
38972 Lancaster Dr, Farmington Hills, MI 48331
930 Dacea Ct APT 31, White Lake, MI 48386
930 Dacea Ct, White Lake, MI 48386
Professional information
See more information about MARK S KAMINSKI at trustoria.com
Dr. Mark S Kaminski, Ann Arbor MI - MD (Doctor of Medicine)
Dr. Mark S Kaminski, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
University MI Comprehnsv Cancr
1500 E Medical Center Dr SUITE B1, Ann Arbor 48109
(734) 647-8901 (Phone)
1500 E Medical Center Dr SUITE B1, Ann Arbor 48109
(734) 647-8901 (Phone)
Certifications:
Internal Medicine, 2006, Medical Oncology, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University MI Comprehnsv Cancr
1500 E Medical Center Dr SUITE B1, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
1500 E Medical Center Dr SUITE B1, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1978
Barnes Jewish Hospital
Graduated: 1979
Barnes Hospital
Graduated: 1981
Stanford University
Stanford University School Of Medicine
Graduated: 1978
Barnes Jewish Hospital
Graduated: 1979
Barnes Hospital
Graduated: 1981
Stanford University
Mark S Kaminski, Ann Arbor MI
Mark S Kaminski, Ann Arbor MI
Specialties:
Internist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
26850 Providence Pkwy, Novi, MI 48374
26850 Providence Pkwy, Novi, MI 48374
Education:
Stanford University, School of Medicine - Doctor of Medicine
Stanford Hospital & Clinics - Fellowship - Oncology (Internal Medicine)
Barnes-Jewish Hospital - Residency - Internal Medicine
Stanford Hospital & Clinics - Fellowship - Oncology (Internal Medicine)
Barnes-Jewish Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Radioimmunotherapy Of Lymphoma Using Anti-Cd20 Antibodies
Radioimmunotherapy Of Lymphoma Using Anti-Cd20 Antibodies
US Patent:
6565827, May 20, 2003
Filed:
Aug 7, 2001
Appl. No.:
09/924360
Inventors:
Mark S. Kaminski - Ann Arbor MI
Gregory M. Butchko - Lake Forest IL
Stephan D. Glenn - Sunnyvale CA
Richard L. Wahl - Ann Arbor MI
Gregory M. Butchko - Lake Forest IL
Stephan D. Glenn - Sunnyvale CA
Richard L. Wahl - Ann Arbor MI
Assignee:
Coulter Pharmaceutical, Inc. - South San Francisco CA
The Regents of the University of Michigan - Ann Arbor MI
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 5100
US Classification:
424 149, 424 153, 4241741, 53038873, 5303913, 5303915
Abstract:
Methods for the treatment of lymphoma by administration of a B cell-specific antibody are described. The invention encompasses providing to a patient both unlabeled antibodies and antibodies labeled with a radioisotope. A principal advantage of the method is that tumor responses can be obtained in a radiometric dose range that does not require hematopoietic stem cell replacement as an adjunct therapy.
Radioimmunotherapy Of Lymphoma Using Anti-Cd20
Radioimmunotherapy Of Lymphoma Using Anti-Cd20
US Patent:
5595721, Jan 21, 1997
Filed:
Sep 16, 1993
Appl. No.:
8/121582
Inventors:
Mark S. Kaminski - Ann Arbor MI
Gregory M. Butchko - Miami Lakes FL
Stephan D. Glenn - Davie FL
Richard L. Wahl - Ann Arbor MI
Gregory M. Butchko - Miami Lakes FL
Stephan D. Glenn - Davie FL
Richard L. Wahl - Ann Arbor MI
Assignee:
Coulter Pharmaceutical, Inc. - Palo Alto CA
International Classification:
A61K 5110
US Classification:
424 149
Abstract:
Methods for the treatment of lymphoma by adminstration of a B cell-specific antibody are described. The invention encompasses providing to a patient both unlabeled antibodies and antibodies labeled with a radioisotope. A principal advantage of the method is that tumor responses can be obtained in a radiometric dose range that does not require hematopoietic stem cell replacement as an adjunct therapy.
Radioimmunotherapy Of Lymphoma Using Anti-Cd20 Antibodies
Radioimmunotherapy Of Lymphoma Using Anti-Cd20 Antibodies
US Patent:
6287537, Sep 11, 2001
Filed:
May 29, 1998
Appl. No.:
9/087392
Inventors:
Mark S. Kaminski - Ann Arbor MI
Gregory M. Butchko - Lake Forest IL
Stephan D. Glenn - Sunnyvale CA
Richard L. Wahl - Ann Arbor MI
Gregory M. Butchko - Lake Forest IL
Stephan D. Glenn - Sunnyvale CA
Richard L. Wahl - Ann Arbor MI
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
Coulter Pharmaceutical, Inc. - South San Francisco CA
Coulter Pharmaceutical, Inc. - South San Francisco CA
International Classification:
A61K 5100, A61K 39395, C12P 2108, C07K 1600
US Classification:
424 149
Abstract:
Methods for the treatment of lymphoma by adminstration of a B cell-specific antibody are described. The invention encompasses providing to a patient both unlabeled antibodies and antibodies labeled with a radioisotope. A principal advantage of the method is that tumor responses can be obtained in a radiometric dose range that does not require hematopoietic stem cell replacement as an adjunct therapy.
Radioimmunotherapy Of Lymphoma Using Anti-Cd20 Antibodies
Radioimmunotherapy Of Lymphoma Using Anti-Cd20 Antibodies
US Patent:
5843398, Dec 1, 1998
Filed:
Apr 26, 1996
Appl. No.:
8/639882
Inventors:
Mark S. Kaminski - Ann Arbor MI
Gregory M. Butchko - Miami Lakes FL
Stephan D. Glenn - Davis FL
Richard L. Wahl - Ann Arbor MI
Gregory M. Butchko - Miami Lakes FL
Stephan D. Glenn - Davis FL
Richard L. Wahl - Ann Arbor MI
Assignee:
Coulter Pharmaceutical, Inc. - Palo Alto CA
Regents of the University of Michigan - Ann Arbor MI
Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 5110, C07K 1600
US Classification:
424 149
Abstract:
Methods for the treatment of lymphoma by administration of a B cell-specific antibody are described. The invention encompasses providing to a patient both unlabeled antibodies and antibodies labeled with a radioisotope. A principal advantage of the method is that tumor responses can be obtained in a radiometric dose range that does not require hematopoietic stem cell replacement as an adjunct therapy.
Radioimmunotherapy Of Lymphoma Using Anti-Cd20 Antibodies
Radioimmunotherapy Of Lymphoma Using Anti-Cd20 Antibodies
US Patent:
6090365, Jul 18, 2000
Filed:
Nov 18, 1997
Appl. No.:
8/972900
Inventors:
Mark S. Kaminski - Ann Arbor MI
Gregory M. Butchko - Miami Lakes FL
Stephan D. Glenn - Davie FL
Richard L. Wahl - Ann Arbor MI
Gregory M. Butchko - Miami Lakes FL
Stephan D. Glenn - Davie FL
Richard L. Wahl - Ann Arbor MI
Assignee:
Coulter Pharmaceutical, Inc. - So. San Francisco CA
Regents of the University of Michigan - Ann Arbor MI
Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 5110, A61K 4505, C07K 1600
US Classification:
424 149
Abstract:
Methods for the treatment of lymphoma by administration of a B cell-specific antibody are described. The invention encompasses providing to a patient both unlabeled antibodies and antibodies labeled with a radioisotope. A principal advantage of the method is that tumor responses can be obtained in a radiometric dose range that does not require hematopoietic stem cell replacement as an adjunct therapy.
Radioimmunotherapy Of Lymphoma Using Anti-Cd20 Antibodies
Radioimmunotherapy Of Lymphoma Using Anti-Cd20 Antibodies
US Patent:
6015542, Jan 18, 2000
Filed:
Sep 10, 1996
Appl. No.:
8/711527
Inventors:
Mark S. Kaminski - Ann Arbor MI
Gregory M. Butchko - Miami Lakes FL
Stephan D. Glenn - Davie FL
Richard L. Wahl - Ann Arbor MI
Gregory M. Butchko - Miami Lakes FL
Stephan D. Glenn - Davie FL
Richard L. Wahl - Ann Arbor MI
Assignee:
Coulter Pharmaceutical, Inc. - South San Francisco CA
The Regents of the University of Michigan - Ann Arbor MI
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 5110, A61K 39395, C07K 1600
US Classification:
424 149
Abstract:
Methods for the treatment of lymphoma by administration of a B cell-specific antibody are described. The invention encompasses providing to a patient both unlabeled antibodies and antibodies labeled with a radioisotope. A principal advantage of the method is that tumor responses can be obtained in a radiometric dose range that does not require hematopoietic stem cell replacement as an adjunct therapy also described is a composition useful in the treatment of lymphoma.